Can the Development of Pediatric Asthma Be Prevented?

A new study led by researchers at Boston Children’s Hospital aims to determine whether monoclonal antibody Xolair (omalizumab) can stop or lessen the progression of asthma in high-risk children.

That’s News

Increasing Exercise May Reduce Depression Despite Genetic Predisposition

People who are genetically predisposed to depression may be able to counteract their increased risk by exercising more, according to Harvard University researchers.

In a new study published in Depression and...

Influenza Vaccination among Young Children: A Case for Improvement

Full influenza vaccination coverage of infants and toddlers in the United States remains alarmingly low, according to recent estimates.

Research Suggests Path toward Fewer Influenza Deaths in Nursing Homes

A study by researchers in Rhode Island and Ohio provides new evidence that well-matched flu vaccinations can save the lives of thousands of elderly residents of nursing homes and prevent thousands more hospitalizations.

Landmark Study May Alter Approach to Peanut Allergy

Research in The New England Journal of Medicine (NEJM) documents an 86 percent lower prevalence of peanut allergy among 5-year-olds who began consuming peanuts prior to 11 months of age than among those who avoided peanuts. The findings may rapidly spawn revised clinical guidelines related to the allergy, which has more than doubled since 2005 in Western countries and is a predominant cause of anaphylaxis.

Airborne Danger: The Hazards of Prenatal Exposure to Pollutants

As researchers continue to learn more about the harms of environmental toxin exposure during the prenatal period, environmental exposures counseling during pregnancy becomes increasingly important. Yet many obstetricians feel poorly equipped to offer this service to patients.

Exposing an Elusive Virus

The most common intrauterine viral infection in the United States, cytomegalovirus (CMV) is responsible for more deaths and long-term problems in children than Down syndrome, fetal alcohol syndrome and neural tube defects. A breakthrough in the understanding of how CMV thwarts normal immune system response is a step forward in the development of a vaccine.